
We believe that Global Best Practice Standards are essential to protecting the rights and wellbeing of clinical trial participants, and delivering innovative new treatments to patients more quickly and safely.
Our leadership's shared mission is to reduce the risk to patients and valuable new treatments; by driving the adoption of global best practice standards for clinical research professionals, sites and other organizations globally, throughout the clinical research ecosystem.
The IAOCR Global Best Practices Board (GBPB) brings together four regional chapters—Americas, APAC, Europe, and the Middle East & Africa—to support global networking and the sharing of best practices across the clinical research industry. As part of IAOCR, a global accrediting body for clinical research and an international accrediting organization for clinical research, the GBPB has evolved from the Global Advisory Board that developed the GCSA Site Certification Standard. It now operates under the IAOCR leadership and governance and the IAOCR executive team, supporting a growing global community of sites and organisations adopting GCSA and IAOCR quality standards. Working collaboratively, the Board identifies and advises on key global and regional challenges, drives positive change across the industry, fosters broader partnerships and opportunities, and champions the importance of global standards in strengthening quality, safety, operational excellence, and ultimately trust among research participants and sponsors. Meet our GBPB members below.

Vice Chair (CRO / Sponsors Representation) – Americas Chapter
Chief Scientific Officer
Merz Aesthetics

Board Member
Professor of Pediatric Oncology
Children's Cancer Hospital Egypt 57357

Board Member
Quality Director
Children's Cancer Hospital Egypt 57357
Board Member
Director Clinical Trials Unit Director
Imam Abdulrahman Bin Faisal University